Skip to main content
. 2018 Mar 13;39(5):708–718. doi: 10.1093/carcin/bgy040

Figure 5.

Figure 5.

Alterations in actionable genes in syCRCs. Each row represents a tumour, and two lesions from one patent were listed together. The mutation type of each actionable gene is marked. Genes were grouped according to pathways. The number of predicted neoantigens for each tumour was shown on the right.